SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-006127
Filing Date
2022-03-14
Accepted
2022-03-14 16:15:16
Documents
15
Period of Report
2022-03-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbyi20220310_8k.htm   iXBRL 8-K 30105
2 EXHIBIT 99.1 ex_345961.htm EX-99.1 8214
7 logo.jpg GRAPHIC 3258
  Complete submission text file 0001437749-22-006127.txt   179016

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20220308.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20220308_def.xml EX-101.DEF 11533
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20220308_lab.xml EX-101.LAB 15415
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20220308_pre.xml EX-101.PRE 11689
9 EXTRACTED XBRL INSTANCE DOCUMENT pbyi20220310_8k_htm.xml XML 2573
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35703 | Film No.: 22736744
SIC: 2834 Pharmaceutical Preparations